Insider Trades47 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 30,000 | $2.98 | $501.8M | -28.24% | +109.24% | $89.5K | -3.10% | — | Stalk |
| Jul 16, 2026 | Sell | CERS | Vivek K Jayaraman | Chief Executive Officer | 16,666 | $3.16 | $501.8M | -28.24% | +109.24% | $52.7K | -0.74% | — | Stalk |
| Jun 30, 2026 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 24,329 | $2.94 | $501.8M | -28.24% | +109.24% | $71.6K | -2.46% | — | Stalk |
| Jun 30, 2026 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 33,676 | $2.94 | $501.8M | -28.24% | +109.24% | $99.1K | -3.07% | — | Stalk |
| Jun 30, 2026 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 42,359 | $2.94 | $501.8M | -28.24% | +109.24% | $124.7K | -2.01% | — | Stalk |
| Jun 30, 2026 | Sell | CERS | William Mariner Greenman | President and CEO | 101,919 | $2.94 | $501.8M | -28.24% | +109.24% | $299.9K | -1.98% | — | Stalk |
| May 29, 2026 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 16,667 | $3.00 | $501.8M | -28.24% | +109.24% | $50.0K | -1.00% | — | Stalk |
| May 1, 2026 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 16,667 | $3.00 | $501.8M | -28.24% | +109.24% | $50.0K | -0.99% | — | Stalk |
| Mar 12, 2026 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 101,740 | $1.66 | $501.8M | -28.24% | +109.24% | $168.6K | -11.57% | — | Stalk |
| Mar 12, 2026 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 127,544 | $1.66 | $501.8M | -28.24% | +109.24% | $211.4K | -10.92% | — | Stalk |
| Mar 12, 2026 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 165,200 | $1.66 | $501.8M | -28.24% | +109.24% | $273.8K | -8.64% | — | Stalk |
| Mar 12, 2026 | Sell | CERS | William Mariner Greenman | President and CEO | 447,757 | $1.66 | $501.8M | -28.24% | +109.24% | $742.0K | -8.22% | — | Stalk |
| Mar 6, 2026 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 30,845 | $2.01 | $501.8M | -28.24% | +109.24% | $61.9K | -2.83% | 10b5-1 | Stalk |
| Mar 6, 2026 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 34,094 | $2.01 | $501.8M | -28.24% | +109.24% | $68.4K | -1.75% | 10b5-1 | Stalk |
| Mar 6, 2026 | Sell | CERS | William Mariner Greenman | President and CEO | 78,187 | $2.01 | $501.8M | -28.24% | +109.24% | $156.8K | -1.42% | 10b5-1 | Stalk |
| Mar 5, 2026 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 83,021 | $2.04 | $501.8M | -28.24% | +109.24% | $169.6K | -3.39% | — | Stalk |
| Mar 5, 2026 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 125,894 | $1.99 | $501.8M | -28.24% | +109.24% | $250.9K | -4.39% | — | Stalk |
| Mar 5, 2026 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 125,894 | $1.99 | $501.8M | -28.24% | +109.24% | $250.9K | -4.39% | 10b5-1 | Stalk |
| Nov 24, 2025 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 55,000 | $1.70 | $501.8M | -28.24% | +109.24% | $93.5K | -7.02% | — | Stalk |
| Mar 13, 2025 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 49,024 | $1.45 | $501.8M | -28.24% | +109.24% | $71.1K | -3.38% | 10b5-1 | Stalk |
| Mar 13, 2025 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 49,024 | $1.45 | $501.8M | -28.24% | +109.24% | $71.1K | -2.98% | 10b5-1 | Stalk |
| Mar 13, 2025 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 59,887 | $1.45 | $501.8M | -28.24% | +109.24% | $86.8K | -3.24% | 10b5-1 | Stalk |
| Mar 13, 2025 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 75,989 | $1.45 | $501.8M | -28.24% | +109.24% | $110.2K | -2.55% | 10b5-1 | Stalk |
| Mar 13, 2025 | Sell | CERS | William Mariner Greenman | President and CEO | 193,913 | $1.45 | $501.8M | -28.24% | +109.24% | $281.2K | -2.27% | 10b5-1 | Stalk |
| Mar 12, 2025 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 113,008 | $1.66 | $501.8M | -28.24% | +109.24% | $187.3K | -10.67% | — | Stalk |
| Mar 7, 2025 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 26,139 | $1.50 | $501.8M | -28.24% | +109.24% | $39.2K | -3.44% | 10b5-1 | Stalk |
| Mar 7, 2025 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 27,457 | $1.50 | $501.8M | -28.24% | +109.24% | $41.1K | -3.19% | 10b5-1 | Stalk |
| Mar 7, 2025 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 31,148 | $1.50 | $501.8M | -28.24% | +109.24% | $46.7K | -3.22% | 10b5-1 | Stalk |
| Mar 7, 2025 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 33,999 | $1.50 | $501.8M | -28.24% | +109.24% | $50.9K | -2.21% | 10b5-1 | Stalk |
| Mar 7, 2025 | Sell | CERS | William Mariner Greenman | President and CEO | 60,984 | $1.50 | $501.8M | -28.24% | +109.24% | $91.4K | -1.40% | 10b5-1 | Stalk |
| Mar 4, 2025 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 10,780 | $1.55 | $501.8M | -28.24% | +109.24% | $16.7K | -1.18% | — | Stalk |
| Mar 4, 2025 | Sell | CERS | William Mariner Greenman | President and CEO | 23,023 | $1.55 | $501.8M | -28.24% | +109.24% | $35.7K | -0.71% | — | Stalk |
| Mar 4, 2025 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 66,292 | $1.58 | $501.8M | -28.24% | +109.24% | $104.9K | -7.08% | — | Stalk |
| Mar 4, 2025 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 69,042 | $1.57 | $501.8M | -28.24% | +109.24% | $108.7K | -6.18% | — | Stalk |
| Mar 3, 2025 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 57,546 | $1.57 | $501.8M | -28.24% | +109.24% | $90.6K | -6.75% | — | Stalk |
| Dec 16, 2024 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 16,667 | $1.71 | $501.8M | -28.24% | +109.24% | $28.5K | -3.51% | — | Stalk |
| Sep 3, 2024 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 82,657 | $2.16 | $501.8M | -28.24% | +109.24% | $178.7K | -6.84% | — | Stalk |
| Aug 15, 2024 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 16,667 | $2.06 | $501.8M | -28.24% | +109.24% | $34.4K | -3.40% | — | Stalk |
| Aug 2, 2024 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 21,605 | $2.50 | $501.8M | -28.24% | +109.24% | $54.0K | -4.70% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | Carol Moore | SVP Reg. & Quality | 20,619 | $2.02 | $501.8M | -28.24% | +109.24% | $41.6K | -2.04% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | Laurence M Corash | Chief Scientific Officer | 28,427 | $2.02 | $501.8M | -28.24% | +109.24% | $57.3K | -0.60% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 35,115 | $2.02 | $501.8M | -28.24% | +109.24% | $70.8K | -3.61% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | Chrystal Jensen | Chief Legal Officer | 35,284 | $2.02 | $501.8M | -28.24% | +109.24% | $71.1K | -3.41% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | Kevin Dennis Green | Chief Financial Officer | 42,555 | $1.99 | $501.8M | -28.24% | +109.24% | $84.9K | -3.27% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | Vivek K Jayaraman | Chief Operating Officer | 53,041 | $2.02 | $501.8M | -28.24% | +109.24% | $106.9K | -2.89% | — | Stalk |
| Mar 13, 2024 | Sell | CERS | William Mariner Greenman | President and CEO | 125,926 | $2.04 | $501.8M | -28.24% | +109.24% | $256.4K | -1.92% | — | Stalk |
| Mar 8, 2024 | Sell | CERS | Richard J Benjamin | Chief Medical Officer | 29,378 | $2.40 | $501.8M | -28.24% | +109.24% | $70.5K | -5.79% | — | Stalk |